<p>Abbreviations: MIA = minimally invasive adenocarcinoma; MP = micropapillary; IMA = invasive mucinous adenocarcinoma; NOS = not otherwise specified.</p
<p>Frequency of EGFR-TKI resistant or co-exiting<sup><a href="http://www.plosone.org/article/info:do...
AIM: Mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K) su...
AIM: Mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K) su...
<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>NSCL SM-EGFR DB = Da...
<p>Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...
<p>The frequencies of each specific mutation at codon 12 of K-RAS in not acceptable (<i>NA</i>) or a...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p>(A) <i>EGFR</i> mutation status across all NSCLC samples is shown. Black segment in the inner cir...
<p>Percentages are the proportion of tumors having a mutation within a subtype, e.g. 37% of Bronchio...
Lung microinvasive adenocarcinoma (MIA) is a newly-defined subtype of early stage non-small cell lun...
Lung microinvasive adenocarcinoma (MIA) is a newly-defined subtype of early stage non-small cell lun...
<p>A. Frequencies of detected mutations in different exons. B. Mutation distribution in exons. C. Mu...
<p>Black bars represent the observed mutation frequency of the respective microsatellites in MMR-DCF...
<p><i>p</i> value represent heterogeneity between groups</p><p>Abbreviations: EMAST = elevated micro...
Snapshots from the MutaGene server show the results of analysis of EGFR gene with a Pan-cancer model...
<p>Frequency of EGFR-TKI resistant or co-exiting<sup><a href="http://www.plosone.org/article/info:do...
AIM: Mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K) su...
AIM: Mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K) su...
<p><i>NA</i> = Not acceptable samples</p><p><i>A</i> = Acceptable samples</p><p>NSCL SM-EGFR DB = Da...
<p>Epidermal growth factor receptor (EGFR) mutation spectrum among patients with EGFR-mutant lung ad...
<p>The frequencies of each specific mutation at codon 12 of K-RAS in not acceptable (<i>NA</i>) or a...
<p>Acceptable (<i>A</i>) and not acceptable (<i>NA</i>) tumor specimens with mutated (MUT) or wild-t...
<p>(A) <i>EGFR</i> mutation status across all NSCLC samples is shown. Black segment in the inner cir...
<p>Percentages are the proportion of tumors having a mutation within a subtype, e.g. 37% of Bronchio...
Lung microinvasive adenocarcinoma (MIA) is a newly-defined subtype of early stage non-small cell lun...
Lung microinvasive adenocarcinoma (MIA) is a newly-defined subtype of early stage non-small cell lun...
<p>A. Frequencies of detected mutations in different exons. B. Mutation distribution in exons. C. Mu...
<p>Black bars represent the observed mutation frequency of the respective microsatellites in MMR-DCF...
<p><i>p</i> value represent heterogeneity between groups</p><p>Abbreviations: EMAST = elevated micro...
Snapshots from the MutaGene server show the results of analysis of EGFR gene with a Pan-cancer model...
<p>Frequency of EGFR-TKI resistant or co-exiting<sup><a href="http://www.plosone.org/article/info:do...
AIM: Mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K) su...
AIM: Mitogen-activated protein kinase (MAPK) cascade and phosphatidylinositol 3-kinase (PI3K) su...